Results 1 to 10 of about 164,299 (193)

Evolution of the Surgical Management of Lung Cancer Invading the Spine: A Single Center Experience

open access: yesCurrent Oncology, 2022
For patients with locally advanced non-small cell lung cancer invading the spine, induction chemoradiotherapy combined with radical en bloc resection is the key to obtaining long-term survival.
Gabrielle Drevet   +8 more
doaj   +1 more source

Azole-Induced Myositis after Combined Lung-Liver Transplantation

open access: yesCase Reports in Transplantation, 2022
Lung transplant recipients experience a high rate of invasive pulmonary aspergillosis infections, for which voriconazole is the treatment of choice.
Sofie Happaerts   +7 more
doaj   +1 more source

First case in Portugal [PDF]

open access: yes, 2021
A significant dysfunction of another organ is usually considered an absolute contraindication for lung transplantation, unless multiorgan transplantation is indicated and practical, as is the case of combined lung-kidney transplantation.
Aires, Inês   +13 more
core   +2 more sources

Lung transplantation [PDF]

open access: yesEinstein (São Paulo), 2015
ABSTRACT Lung transplantation is a globally accepted treatment for some advanced lung diseases, giving the recipients longer survival and better quality of life. Since the first transplant successfully performed in 1983, more than 40 thousand transplants have been performed worldwide. Of these, about seven hundred were in Brazil.
Afonso Júnior, José Eduardo   +7 more
openaire   +5 more sources

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report

open access: yesBMC Pulmonary Medicine, 2022
Background Variability in triazole plasma concentrations by drug interactions is well known. An interaction between voriconazole and flucloxacillin has already been described.
Saartje Verfaillie   +4 more
doaj   +1 more source

Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases

open access: yesERJ Open Research, 2023
Research questions Patients with severe pulmonary hypertension associated with chronic lung disease have a poor prognosis. Targeted pulmonary arterial hypertension therapies might improve exercise capacity and outcome, but there are no guidelines on ...
Romain Naud   +10 more
doaj   +1 more source

Pneumonectomy for Unilateral Proximal Interruption of Pulmonary Artery: A Case Series from the Literature

open access: yesLife, 2023
Background: Unilateral proximal interruption of the pulmonary artery (UPIPA) is a rare congenital disease, and its optimal management remains undefined in the existing literature.
Giovanni Mattioni   +5 more
doaj   +1 more source

Lobar lung transplantation-Is it comparable with standard lung transplantation? [PDF]

open access: yesTransplant International, 2014
Objective: Lobar lung transplantation (LLuTX) is a therapeutic option mainly for urgent small recipients. Only series with limited numbers have been reported. This approach is technically more demanding than standard LuTX or simple downsizing by wedge resections. In our center this approach was liberally[for full text, please go to the a.m. URL]
Alexis Slama   +10 more
openaire   +3 more sources

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

open access: yesRespiratory Research, 2020
Background Serum chitotriosidase is a promising biomarker that has shown high specificity and sensitivity in patients with sarcoidosis. The aim of this study was to investigate correlations between serum chitotriosidase, clinical phenotypes, disease ...
David Bennett   +14 more
doaj   +1 more source

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

open access: yesRespiratory Research, 2020
After publication of our article [1] the authors have notified us that one of the names has been incorrectly tagged.
David Bennett   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy